June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Mesenchymal stem cells induce Foxp3-Tregs to suppress effector T cells and protect against retinal ischemic injury
Author Affiliations & Notes
  • Rajashekhar Gangaraju
    Ophthalmology, The University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee, United States
  • Mona Agrawal
    Ophthalmology, The University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee, United States
  • Pratheepa Rasiah
    Ophthalmology, The University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee, United States
  • Amandeep Bajwa
    Surgery, The University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee, United States
  • Rajasingh Johnson
    Biomedicine, The University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee, United States
  • Footnotes
    Commercial Relationships   Rajashekhar Gangaraju, Cell Care Therapeutics, Inc (P), Cell Care Therapeutics, Inc (I); Mona Agrawal, None; Pratheepa Rasiah, None; Amandeep Bajwa, None; Rajasingh Johnson, None
  • Footnotes
    Support  NH Grant EY023427; DOD Grant W81XWH-16-1-0778
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3301. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rajashekhar Gangaraju, Mona Agrawal, Pratheepa Rasiah, Amandeep Bajwa, Rajasingh Johnson; Mesenchymal stem cells induce Foxp3-Tregs to suppress effector T cells and protect against retinal ischemic injury. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3301.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mesenchymal stem/stromal cells (MSC) are well known for immunomodulation; however, the mechanisms involved in their benefits in the ischemic retina are unknown. In this study, we tested the hypothesis that MSC via upregulation of transcription factor forkhead box P3 (Foxp3) in T cells elicit immune modulation and thus protect against ischemic retinal damage

Methods : MSCs were generated from urine epithelial cells derived induced pluripotent stem cells (iPSC) through non-insertional reprogramming (iMSCs). Mitochondria transfer from MSC to immune cells was assessed by confocal microscopy, and oxygen consumption rates (OCR) were measured using Seahorse Flux Bioanalyzer. Activated splenocytes co-cultured with iMSC in differentiation medium were assessed with anti-Foxp3 antibody and analyzed by flow cytometry. Unilateral retinal ischemia reperfusion (I/R) were done in adult C57BL/6 mice by transiently elevating the intraocular pressure for 1 h. Uninjured eyes served as I/R controls. After 1 day of reperfusion, the animals were randomized to receive intravitreal iMSC (1000 cells/1mL) or saline (1mL). After 7 days, the retinal function was assessed by Electroretinogram (ERG). The retinal extracts were processed by qRT-PCR, and the retinal flat mounts were processed by confocal microscopy for Foxp3+ cells.

Results : In in-vitro cultures, iMSC transferred mitochondria to immune cells via F-actin nanotubes, significantly increased OCR for basal respiration and ATP production, suppressed effector T cells, and promoted differentiation of CD4+CD25+ Tregs in co-culture with mouse splenocytes. In in-vivo studies, iMSCs in I/R eye significantly increased Tregs in the retina compared to saline injected I/R eyes (63.4 ± 14.29 v/s 29.99 ± 6.69 cells/mm2, p<0.05, anova). Furthermore, iMSC injected I/R eyes had decrease in retinal inflammation (IL1b: 6.09±1.54 v/s 27.08±8.69 fold p<0.01; Ccl2: 3.52±0.96 v/s 13.6±2.7 fold p<0.001,anova) and improved b-wave amplitudes compared to saline injected I/R eyes (at 1cd.s.m2 139±48 v/s 48±10 µvolt, p=0.05, t-test).

Conclusions : Our study demonstrates that iPSC derived MSCs can transfer mitochondria to T cells to enhance differentiation into Foxp3 Tregs. Additionally, our current data demonstrates that MSC can improve the retina's immune function through upregulation of Tregs to decrease inflammation to reduce I/R injury-induced retinal degeneration

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×